JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A1718 Posaconazole

Target: Cytochrome P450 (CYP450)|sterol demethylase

Summary: Sterol C14ɑ demethylase inhibitor

≥35.04 mg/mL
A5017 Motesanib Diphosphate (AMG-706)

Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor

≥28.45 mg/mL
A2822 AC480 (BMS-599626)

Target: EGFR

Summary: HER1/2 inhibitor,selective and efficacious

≥28.35 mg/mL
A2974 Foretinib (GSK1363089)
1 Citation

Summary: VEGF and HGF receptor inhibitor

≥31.65 mg/mL
A1684 Aprepitant

Target: Substance P/NK1 Receptor

Summary: Substance P (SP) inhibitor

≥26.72 mg/mL
A2415 Acitretin

Target: RARs

Summary: Metabolite of etretinate

insoluble in EtOH; insoluble in H2O; ≥16.32 mg/mL
A1302 GSK1904529A

Target: Insulin and Insulin-like Receptors

Summary: Selective IGF-1R/IR inhibitor

≥42.6 mg/mL
A1987 Ki16425
4 Citation

Target: LPA Receptors

Summary: LPA receptor antagonist

≥23.75 mg/mL
A1745 Galanthamine HBr

Summary: Acetylcholinesterase inhibitor

insoluble in ETOH; ≥36.9 mg/mL
A2487 Odanacatib (MK-0822)

Target: Cathepsins

Summary: Cathepsin K,potent and selective

insoluble in EtOH; insoluble in H2O; ≥17.7 mg/mL